Inventor · disambiguated record
Valeria Lifke
Also filed as: LIFKE VALERIA
13 granted patents·22 pending applications·79 citations·filing 2007–2024
89Inventor score
Top patents by PatentIndex Score
35 records- 0192US9290567B2Use of an anti-Tau pS422 antibody for the treatment of brain diseasesHOFFMANN LA ROCHE·Filed 2013·Granted Mar 22, 2016·25 cites·2 claims
- 0290US10287352B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2016·Granted May 14, 2019·10 cites·21 claims
- 0390US8609097B2Use of an anti-Tau pS422 antibody for the treatment of brain diseasesBOHRMANN BERND·Filed 2010·Granted Dec 17, 2013·28 cites·10 claims
- 0489US11130810B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·4 cites·36 claims
- 0586US9309319B2Antibodies against human IL33R and uses thereofHOFFMANN LA ROCHE·Filed 2014·Granted Apr 12, 2016·8 cites·7 claims
- 0684US2024270844A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0783US2024294642A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0881US2023183349A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0980US2023279109A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1078US2023143310A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1177US8859737B2Anti-HER3 antibodies and uses thereofBOSSENMAIER BIRGIT·Filed 2010·Granted Oct 14, 2014·3 cites·7 claims
- 1277US2025137028A1Method for obtaining immunoglobulin encoding nucleic acidHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1376US2022363755A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1472US9611331B2Anti-HER3 antibodies and uses thereofROCHE GLYCART AG·Filed 2014·Granted Apr 4, 2017·1 cites·13 claims
- 1570US12391757B2Bispecific antibodies specific for PD1 and TIM3HOFFMANN LA ROCHE·Filed 2021·Granted Aug 19, 2025·0 cites·20 claims
- 1670US9339560B2Method for determining the anti-tumor efficacy of monoclonal antibodiesBOSSENMAIER BIRGIT·Filed 2009·Granted May 17, 2016·0 cites·2 claims
- 1763US2020299385A1Antibodies binding to human and cynomolgus cd3 epsilonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 1863US2019382480A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1963US2020325224A1Antibodies binding to human and cynomolgus cd3 epsilonHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2062US2010105073A1Method for the production of antibodiesLIFKE ALEXANDER·Filed 2009·Application pending·0 cites
- 2162US2019382489A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 2260US8884096B2Method for the production of antibodiesHOFFMANN LA ROCHE·Filed 2013·Granted Nov 11, 2014·0 cites·11 claims
- 2359US10196456B2Anti-HER3 antibodies and uses thereofROCHE GLYCART AG·Filed 2017·Granted Feb 5, 2019·0 cites·13 claims
- 2458US2018072804A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2556US2007266448A1Method for the production of antibodiesLIFKE ALEXANDER·Filed 2007·Application pending·0 cites
- 2656US2017247454A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2755US2017233475A1Antibodies binding to human and cynomolgus cd3 epsilonHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2854US2016257749A1Anti-tim3 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2953US8785153B2Antibodies against human IL33R and uses thereofFERTIG GEORG·Filed 2012·Granted Jul 22, 2014·0 cites·16 claims
- 3053US2017107550A1Method for obtaining immunoglobulin encoding nucleic acidHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 3153US2021132085A1Methods of identifying an individual as having or being at risk of developing an amyloid-positive dementia based on marker molecules and related usesGENENTECH INC·Filed 2021·Application pending·0 cites
- 3252US2012195903A1Method for the production of antibodiesLIFKE ALEXANDER·Filed 2012·Application pending·0 cites
- 3345US9399670B2Method for obtaining immunoglobulin encoding nucleic acidKRELL HANS-WILLI·Filed 2010·Granted Jul 26, 2016·0 cites·8 claims
- 3438US2018078655A1Immunoconjugates for specific induction of t cell cytotoxicity against a target cellHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 3538US2015024434A1METHOD FOR OBTAINING FAB FRAGMENTS FROM SINGLE ANTIBODY PRODUCING CELLS BY MULTIPLEXED CPR IN COMBINATION WITH TaqMan PROBESHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Valeria Lifke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →